Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Non Operating Income (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Non Operating Income for 10 consecutive years, with $12000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 47.83% to $12000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15000.0 through Dec 2025, down 93.45% year-over-year, with the annual reading at -$27000.0 for FY2025, 82.0% up from the prior year.
  • Non Operating Income hit $12000.0 in Q4 2025 for vTv Therapeutics, up from -$34000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $2.9 million in Q2 2021 to a low of -$3.6 million in Q3 2023.
  • Historically, Non Operating Income has averaged -$192388.9 across 5 years, with a median of $38000.0 in 2022.
  • Biggest YoY gain for Non Operating Income was 532.08% in 2023; the steepest drop was 1023.46% in 2023.
  • Year by year, Non Operating Income stood at $634000.0 in 2021, then increased by 14.35% to $725000.0 in 2022, then plummeted by 76.83% to $168000.0 in 2023, then crashed by 86.31% to $23000.0 in 2024, then crashed by 47.83% to $12000.0 in 2025.
  • Business Quant data shows Non Operating Income for VTVT at $12000.0 in Q4 2025, -$34000.0 in Q3 2025, and $54000.0 in Q2 2025.